Log in with your email address username.


[Correspondence] Exclusive and partial enteral nutrition for Crohn’s disease

In their Article, Subra Kugathasan and colleagues (April 29, p 1710)1 validated a risk-stratification model showing that early anti-tumour necrosis factor α therapy in patients with Crohn’s disease was associated with reduced incidence of internal penetrating complications, although not stricturing complications.